Existing treatments for acute migraine are not effective for all children and adolescents,
and can cause side effects. Investigator propose a dose-finding study of melatonin for acute
migraine treatment in children and adolescents to determine the best dose to bring forward in
a future fully-powered efficacy trial.
Phase:
Phase 2
Details
Lead Sponsor:
Amy Gelfand University of California, San Francisco